Bulletin of the World Health Organization

Contraceptive injections by community health workers in Uganda: a nonrandomized community trial

John Stanback, Anthony K Mbonye, Martha Bekiita

Volume 85, Number 10, October 2007, 768-773

Table 2. Continuation and client reports of care received

CRHW % (n = 449)a Clinic % (n = 328)a P-valueb
Client received 2nd injection
88
85
0.38
Satisfied or highly satisfied with:



provider care
95
93
0.27
DMPA as contraceptive method
93
90
0.15
Standard quality indicators:



provider discussed side-effects
85
86
0.49
client received written appointment slip
87
91
0.10
provider discussed STI/HIV/AIDS
69
71
0.58
provider offered condoms
36
34
0.64
provider explained that DMPA does not protect against HIV
80
81
0.75
Spontaneous recall of other methods mentioned by family planning provider:



pills
86
89
0.21
Norplant
47
65
< 0.01
IUD
13
17
0.06
female sterilization
20
32
< 0.01
condoms
66
59
0.04
Spontaneous recall of common side-effects:



irregular bleeding
55
54
0.74
heavy bleeding
49
49
0.97
spotting
25
33
0.03
amenorrhoea
15
20
0.08
headache
40
32
0.02
weight gain
26
32
0.04
Injection-related problems reported:c



infections/abscesses
0.0
0.0

very painful injection
0.7
0.0
0.27
temporary numbness 0.7 0.3 0.64

CRHW, community-based reproductive health workers; IUV, intrauterine device.a Maximum n for followed CRHW and clinic clients; some cells have non-response missing values.b P-values based on Mantel-Haenszel chi-square test, unless otherwise noted.c P-values based on Fisher’s exact test.

[an error occurred while processing this directive]